DOCGO INC (DCGO) Stock Fundamental Analysis
NASDAQ:DCGO - Nasdaq - US2560861096 - Common Stock - Currency: USD
Taking everything into account, DCGO scores 5 out of 10 in our fundamental rating. DCGO was compared to 102 industry peers in the Health Care Providers & Services industry. DCGO has an excellent financial health rating, but there are some minor concerns on its profitability. DCGO is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
DCGO had positive earnings in the past year.
DCGO had a positive operating cash flow in the past year.
Of the past 5 years DCGO 4 years were profitable.
In multiple years DCGO reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a decent Return On Assets value of 4.39%, DCGO is doing good in the industry, outperforming 76.47% of the companies in the same industry.
Looking at the Return On Equity, with a value of 6.23%, DCGO is in the better half of the industry, outperforming 61.76% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.17%, DCGO is in the better half of the industry, outperforming 69.61% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for DCGO is below the industry average of 9.37%.
The 3 year average ROIC (6.13%) for DCGO is below the current ROIC(7.17%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.39% | ||
| ROE | 6.23% | ||
| ROIC | 7.17% |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)6.13%
ROIC(5y)N/A
1.3 Margins
DCGO has a better Profit Margin (3.24%) than 67.65% of its industry peers.
In the last couple of years the Profit Margin of DCGO has declined.
Looking at the Operating Margin, with a value of 5.35%, DCGO is in the better half of the industry, outperforming 61.76% of the companies in the same industry.
DCGO's Operating Margin has declined in the last couple of years.
DCGO has a Gross Margin of 34.64%. This is in the better half of the industry: DCGO outperforms 62.75% of its industry peers.
In the last couple of years the Gross Margin of DCGO has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.35% | ||
| PM (TTM) | 3.24% | ||
| GM | 34.64% |
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DCGO is destroying value.
DCGO has less shares outstanding than it did 1 year ago.
DCGO has a worse debt/assets ratio than last year.
2.2 Solvency
DCGO has an Altman-Z score of 2.69. This is not the best score and indicates that DCGO is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.69, DCGO is doing good in the industry, outperforming 60.78% of the companies in the same industry.
DCGO has a debt to FCF ratio of 0.69. This is a very positive value and a sign of high solvency as it would only need 0.69 years to pay back of all of its debts.
The Debt to FCF ratio of DCGO (0.69) is better than 87.25% of its industry peers.
DCGO has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.12, DCGO is doing good in the industry, outperforming 72.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 0.69 | ||
| Altman-Z | 2.69 |
ROIC/WACC0.88
WACC8.13%
2.3 Liquidity
DCGO has a Current Ratio of 2.50. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.50, DCGO belongs to the best of the industry, outperforming 84.31% of the companies in the same industry.
DCGO has a Quick Ratio of 2.50. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.50, DCGO belongs to the best of the industry, outperforming 84.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.5 | ||
| Quick Ratio | 2.5 |
3. Growth
3.1 Past
DCGO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -65.00%.
The Earnings Per Share has been decreasing by -9.93% on average over the past years.
The Revenue has decreased by -1.24% in the past year.
Measured over the past years, DCGO shows a very strong growth in Revenue. The Revenue has been growing by 24.60% on average per year.
EPS 1Y (TTM)-65%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-190%
Revenue 1Y (TTM)-1.24%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-50.01%
3.2 Future
DCGO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -35.00% yearly.
DCGO is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -15.82% yearly.
EPS Next Y-101.68%
EPS Next 2Y-33.71%
EPS Next 3Y-35%
EPS Next 5YN/A
Revenue Next Year-49.7%
Revenue Next 2Y-27.64%
Revenue Next 3Y-15.82%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 21.21, DCGO is valued on the expensive side.
DCGO's Price/Earnings ratio is a bit cheaper when compared to the industry. DCGO is cheaper than 68.63% of the companies in the same industry.
DCGO is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.05, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 13.00, the valuation of DCGO can be described as correct.
Based on the Price/Forward Earnings ratio, DCGO is valued cheaply inside the industry as 82.35% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.07, DCGO is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.21 | ||
| Fwd PE | 13 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DCGO is valued cheaply inside the industry as 99.02% of the companies are valued more expensively.
100.00% of the companies in the same industry are more expensive than DCGO, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.28 | ||
| EV/EBITDA | 1.31 |
4.3 Compensation for Growth
DCGO's earnings are expected to decrease with -35.00% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-33.71%
EPS Next 3Y-35%
5. Dividend
5.1 Amount
DCGO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:DCGO (5/16/2025, 10:06:59 AM)
1.485
+0.09 (+6.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners54.36%
Inst Owner Change2.58%
Ins Owners7.98%
Ins Owner Change11.81%
Market Cap147.16M
Analysts83.08
Price Target5.15 (246.8%)
Short Float %7.23%
Short Ratio5.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.17%
Min EPS beat(2)-19.26%
Max EPS beat(2)0.93%
EPS beat(4)2
Avg EPS beat(4)-1.61%
Min EPS beat(4)-19.26%
Max EPS beat(4)20.4%
EPS beat(8)2
Avg EPS beat(8)-57.43%
EPS beat(12)5
Avg EPS beat(12)-14.97%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.93%
Min Revenue beat(2)-8.47%
Max Revenue beat(2)-1.39%
Revenue beat(4)1
Avg Revenue beat(4)-2.55%
Min Revenue beat(4)-8.47%
Max Revenue beat(4)0.21%
Revenue beat(8)4
Avg Revenue beat(8)2.03%
Revenue beat(12)8
Avg Revenue beat(12)3.71%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-18.74%
EPS NQ rev (1m)-7.15%
EPS NQ rev (3m)-191.86%
EPS NY rev (1m)-50%
EPS NY rev (3m)-104%
Revenue NQ rev (1m)-0.98%
Revenue NQ rev (3m)-6.87%
Revenue NY rev (1m)-0.72%
Revenue NY rev (3m)-1.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.21 | ||
| Fwd PE | 13 | ||
| P/S | 0.24 | ||
| P/FCF | 2.28 | ||
| P/OCF | 2.09 | ||
| P/B | 0.46 | ||
| P/tB | 0.59 | ||
| EV/EBITDA | 1.31 |
EPS(TTM)0.07
EY4.71%
EPS(NY)0.11
Fwd EY7.69%
FCF(TTM)0.65
FCFY43.83%
OCF(TTM)0.71
OCFY47.8%
SpS6.22
BVpS3.24
TBVpS2.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.39% | ||
| ROE | 6.23% | ||
| ROCE | 9.89% | ||
| ROIC | 7.17% | ||
| ROICexc | 9.5% | ||
| ROICexgc | 12.94% | ||
| OM | 5.35% | ||
| PM (TTM) | 3.24% | ||
| GM | 34.64% | ||
| FCFM | 10.46% |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)6.13%
ROIC(5y)N/A
ROICexc(3y)10.39%
ROICexc(5y)N/A
ROICexgc(3y)17.2%
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexcg growth 3Y-25.16%
ROICexcg growth 5YN/A
ROICexc growth 3Y-25.56%
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score8
Asset Turnover1.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 0.69 | ||
| Debt/EBITDA | 0.82 | ||
| Cap/Depr | 36.74% | ||
| Cap/Sales | 0.95% | ||
| Interest Coverage | 15.41 | ||
| Cash Conversion | 143.88% | ||
| Profit Quality | 322.63% | ||
| Current Ratio | 2.5 | ||
| Quick Ratio | 2.5 | ||
| Altman-Z | 2.69 |
F-Score8
WACC8.13%
ROIC/WACC0.88
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-190%
EPS Next Y-101.68%
EPS Next 2Y-33.71%
EPS Next 3Y-35%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.24%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-50.01%
Revenue Next Year-49.7%
Revenue Next 2Y-27.64%
Revenue Next 3Y-15.82%
Revenue Next 5YN/A
EBIT growth 1Y34.3%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-58.26%
EBIT Next 3Y0.41%
EBIT Next 5YN/A
FCF growth 1Y186.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y209.52%
OCF growth 3YN/A
OCF growth 5YN/A